Discovery Grant Program (DGP)
Forecasted
The Discovery Grant Program (DGP) from the Leukemia & Lymphoma Society funds innovative basic research and technology to uncover mechanisms, detection methods, and therapeutic targets in blood cancer.
Funder: Leukemia & Lymphoma Society
Due Dates (Anticipated): August 2027 (Letter of Intent) | November 2027 (Full Application)
Funding Amounts: Up to $250,000/year ($750,000 total over 3 years, including max 10% indirect costs).
Summary: Supports innovative foundational research and technology development to uncover new mechanisms, detection methods, and therapeutic targets in blood cancer.
Key Information: Forecasted dates—program details may change; check the program page for updates.
Description
The Discovery Grant Program (DGP) from the Leukemia & Lymphoma Society (now Blood Cancer United) is designed to advance basic research and technological innovation in the field of blood cancers. The program funds established investigators pursuing foundational studies that deepen understanding of blood cancer mechanisms, foster the development of innovative detection and monitoring methods, and identify novel therapeutic targets. DGP supports proof-of-concept projects, encouraging exploration of new biological insights and the development of groundbreaking approaches to improve blood cancer treatment and patient outcomes.
